AccessibilityHelpAbout Us
FusionPharm logo

FusionPharm(OTC) FSPM

Market Cap$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1993)-100%
5 Year+0%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
FusionPharm last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-28
FusionPharm stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9,900%USD 0.002026-08-04
1 month+0%USD 0.002026-07-27
3 month+0%USD 0.002026-05-29
Year to date+0%USD 0.002025-12-30
1 year+0%USD 0.002025-08-22
3 year+0%USD 0.002023-08-29
5 year+0%USD 0.002021-08-27
Since inception-100%USD 1,874,906.251993-04-27

FusionPharm Financials at a Glance

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-31.85 (Low)

Price

$0.00

Volume

2

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

FSPM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About FusionPharm

FusionPharm, Inc. is a company focused on the development, manufacturing, and sale of advanced indoor cultivation systems. The PharmPod brand offers enclosed growing units that serve a diverse clientele, including commercial businesses and individual growers.

Products and Services
  • Advanced indoor cultivation systems under the PharmPod brand
  • Enclosed growing units for various plant types
  • Targeted distribution to commercial and academic sectors
Growth Outlook
  • Established market presence since 1998, enhancing brand recognition
  • Increasing demand for indoor cultivation solutions across the U.S.
  • Potential for expansion into new markets and customer segments
Financial Highlights
  • Market capitalization of $1,259, indicating growth potential
  • Stock price range between $0.0001 and $0.0002 over the year
  • Consistent trading volume, reflecting investor interest
FusionPharm, Inc. operates in the medical and pharmaceutical industry, with a focus on innovative cultivation technologies. The company has a long-standing history, having transitioned from Baby Bee Bright Corp. to its current identity in 2011. With a small team of four employees, FusionPharm is headquartered in Commerce City, Colorado. The company's products cater to a growing market that values sustainable and efficient cultivation methods. As the demand for indoor growing solutions continues to rise, FusionPharm is well-positioned to capitalize on emerging opportunities in the sector.
AI Generated • Sep 9, 2026

Industry

Food Products

Sector

Consumer Staples

Headquarters

Commerce City, CO 80022, US

FSPM Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.59M

Volume

2

Avg. Volume

583.508

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

FusionPharm Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BNKLBionik Laboratories Corp.
$0.00+0.00%
OHAQOracle Healthcare Acquisition Corp.
$0.00+0.00%
NMTRQ9 Meters Biopharma, Inc.
$0.00+0.00%
BGMDBG Medicine, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$150.80+0.02%
INTCIntel
$100.85-0.05%
NVDANvidia
$217.86-0.02%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.61+0.08%

Questions About FSPM

What is the current price of FusionPharm?

FusionPharm is trading at $0.00 per share.

What is the 52-week range for FusionPharm?

Over the past 52 weeks, FusionPharm has traded between $0.00 and $0.00.

How much debt does FusionPharm have?

FusionPharm total debt is unavailable.

How much cash does FusionPharm have on hand?

FusionPharm does not have cash on hand data available.

What is FusionPharm’s dividend yield?

FusionPharm does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services